The Federal High Court in Abuja has affirmed the authority of the Federal Competition and Consumer Protection Commission to investigate complaints involving medical negligence, a ruling that significantly expands consumer protection oversight into the healthcare sector. Justice Emeka Nwite delivered the decision on April 15 in a suit filed by Life Bridge Medical Diagnostic Centre Ltd, which had challenged the commission’s jurisdiction over healthcare‑related matters.
The company had argued that the FCCPC could not act without a prior agreement with the Medical and Dental Council of Nigeria. The court dismissed this claim, holding that the commission’s powers are clearly defined under the Federal Competition and Consumer Protection Act. Justice Nwite ruled that healthcare services fall within the scope of consumer protection oversight, and the absence of a formal agreement with another regulator does not limit the FCCPC’s statutory authority.
Reacting to the judgment, FCCPC Executive Vice Chairman Tunji Bello said the decision reinforces consumer rights across all sectors, including healthcare. He described it as a significant affirmation that consumers are entitled to protection and legal redress wherever services are provided for a fee. Bello added that the ruling clarifies that professional regulation and consumer protection serve distinct but complementary roles. The FCCPC does not replace sector regulators but ensures that service providers uphold fairness and legal standards.
From an economic perspective, the ruling has profound implications for Nigeria’s healthcare industry, which is a significant and growing sector of the economy. Patients pay substantial sums for medical services, and the absence of a clear consumer redress mechanism has historically left them vulnerable to negligence without recourse beyond professional disciplinary bodies. By affirming that healthcare consumers are entitled to the same protections as consumers in any other sector, the court has opened a new avenue for accountability. This could spur improvements in service quality, attract private investment by reducing reputational risk, and ultimately enhance trust in the healthcare system. However, healthcare providers may face increased compliance costs and litigation risk, which could be passed on to patients.
